Changlin Pang
Biography
Changlin Pang, PhD., Platform Integration Lead of InchFab Inc., received the B.S. and M.S. degrees in Precision instruments from Tsinghua University, China in 2002, and his M.S. and Ph.D. degrees in Electrical Engineering from Caltech with his Ph.D. project of polymer neural electrodes for a neural prosthesis system in 2007. Dr. Pang invented the world’s smallest implantable programmable ocular drug delivery pump for AMD treatment, started Replenish, Inc. which was invested by Alcon in 2008. He later joined Alcon for commercializing this micropump in 2015. Dr. Pang was the Co-founder and CTO of Golden Eye Bionics from 2017 to 2024 to develop and commercialize a new generation of retinal prosthesis products. Dr. Pang has more than 50 approved and pending patent applications.
Company Profile
InchFab
Company Profile
InchFab pioneered Application Specific Fabs for the new era of chips, delivering the world’s only drop-in, ready-to-use modular fabrication lines with as short as 6-month delivery lead times. These $1-10M agile fabs enable state-of-the-art wafer processing at a fraction of traditional $1B+ costs. The company provides complete solutions including turnkey process flows, comprehensive education courses, and foundry services. By combining low CapEx, scalable throughput, and a proprietary process library, InchFab democratizes semiconductor manufacturing for workforce development, rapid prototyping, and production across specialized chips, non-IC devices, and localized supply chains.RetryM
Product & Service
Application Specific Fabs
